Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 460

1.

Increased (18)F-deoxyglucose uptake in the lung during the first weeks of radiotherapy is correlated with subsequent Radiation-Induced Lung Toxicity (RILT): a prospective pilot study.

De Ruysscher D, Houben A, Aerts HJ, Dehing C, Wanders R, Ollers M, Dingemans AM, Hochstenbag M, Boersma L, Borger J, Dekker A, Lambin P.

Radiother Oncol. 2009 Jun;91(3):415-20. doi: 10.1016/j.radonc.2009.01.004. Epub 2009 Feb 3.

PMID:
19195730
[PubMed - indexed for MEDLINE]
2.

[¹⁸F]fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation-induced lung toxicity in non-small-cell lung cancer patients.

Petit SF, van Elmpt WJ, Oberije CJ, Vegt E, Dingemans AM, Lambin P, Dekker AL, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):698-705. doi: 10.1016/j.ijrobp.2010.06.016. Epub 2010 Sep 29.

PMID:
20884128
[PubMed - indexed for MEDLINE]
3.

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):78-86.

PMID:
15093902
[PubMed - indexed for MEDLINE]
4.

Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning.

Hong R, Halama J, Bova D, Sethi A, Emami B.

Int J Radiat Oncol Biol Phys. 2007 Mar 1;67(3):720-6.

PMID:
17293230
[PubMed - indexed for MEDLINE]
5.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
[PubMed - indexed for MEDLINE]
6.

Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).

Edet-Sanson A, Dubray B, Doyeux K, Back A, Hapdey S, Modzelewski R, Bohn P, Gardin I, Vera P.

Radiother Oncol. 2012 Feb;102(2):251-7. doi: 10.1016/j.radonc.2011.07.023. Epub 2011 Aug 30.

PMID:
21885145
[PubMed - indexed for MEDLINE]
7.

Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.

Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM.

J Nucl Med. 2005 Aug;46(8):1342-8.

PMID:
16085592
[PubMed - indexed for MEDLINE]
Free Article
8.

Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer?

Abramyuk A, Tokalov S, Zöphel K, Koch A, Szluha Lazanyi K, Gillham C, Herrmann T, Abolmaali N.

Radiother Oncol. 2009 Jun;91(3):399-404. doi: 10.1016/j.radonc.2009.01.003. Epub 2009 Jan 23.

PMID:
19168248
[PubMed - indexed for MEDLINE]
9.

18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate?

Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD.

J Nucl Med. 2006 Nov;47(11):1808-12.

PMID:
17079814
[PubMed - indexed for MEDLINE]
Free Article
10.

Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.

van Der Wel A, Nijsten S, Hochstenbag M, Lamers R, Boersma L, Wanders R, Lutgens L, Zimny M, Bentzen SM, Wouters B, Lambin P, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):649-55.

PMID:
15708242
[PubMed - indexed for MEDLINE]
11.

Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study.

Yu J, Li X, Xing L, Mu D, Fu Z, Sun X, Sun X, Yang G, Zhang B, Sun X, Ling CC.

Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1468-74. doi: 10.1016/j.ijrobp.2009.01.019. Epub 2009 May 21.

PMID:
19464822
[PubMed - indexed for MEDLINE]
12.

Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study.

Petit SF, Aerts HJ, van Loon JG, Offermann C, Houben R, Winkens B, Ollers MC, Lambin P, De Ruysscher D, Dekker AL.

Radiother Oncol. 2009 Jun;91(3):393-8. doi: 10.1016/j.radonc.2009.02.020. Epub 2009 Mar 26.

PMID:
19328570
[PubMed - indexed for MEDLINE]
13.

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.

J Clin Oncol. 2004 Aug 15;22(16):3255-60.

PMID:
15310769
[PubMed - indexed for MEDLINE]
14.

Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer.

Jeong HJ, Min JJ, Park JM, Chung JK, Kim BT, Jeong JM, Lee DS, Lee MC, Han SK, Shim YS.

Nucl Med Commun. 2002 Sep;23(9):865-70.

PMID:
12195091
[PubMed - indexed for MEDLINE]
15.

The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.

Zhao L, Sheldon K, Chen M, Yin MS, Hayman JA, Kalemkerian GP, Arenberg D, Lyons SE, Curtis JL, Davis M, Cease KB, Brenner D, Anscher MS, Lawrence TS, Kong FM.

Lung Cancer. 2008 Feb;59(2):232-9. Epub 2007 Oct 1.

PMID:
17905467
[PubMed - indexed for MEDLINE]
16.

A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.

Kong FM, Frey KA, Quint LE, Ten Haken RK, Hayman JA, Kessler M, Chetty IJ, Normolle D, Eisbruch A, Lawrence TS.

J Clin Oncol. 2007 Jul 20;25(21):3116-23.

PMID:
17634490
[PubMed - indexed for MEDLINE]
17.

Time trends in the maximal uptake of FDG on PET scan during thoracic radiotherapy. A prospective study in locally advanced non-small cell lung cancer (NSCLC) patients.

van Baardwijk A, Bosmans G, Dekker A, van Kroonenburgh M, Boersma L, Wanders S, Ollers M, Houben R, Minken A, Lambin P, De Ruysscher D.

Radiother Oncol. 2007 Feb;82(2):145-52. Epub 2007 Jan 26.

PMID:
17258339
[PubMed - indexed for MEDLINE]
18.

Defining a radiotherapy target with positron emission tomography.

Black QC, Grills IS, Kestin LL, Wong CY, Wong JW, Martinez AA, Yan D.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1272-82.

PMID:
15519800
[PubMed - indexed for MEDLINE]
19.

Correlation of 18F-FLT and 18F-FDG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer.

Yamamoto Y, Nishiyama Y, Ishikawa S, Nakano J, Chang SS, Bandoh S, Kanaji N, Haba R, Kushida Y, Ohkawa M.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1610-6. Epub 2007 May 26.

PMID:
17530250
[PubMed - indexed for MEDLINE]
20.

Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer.

Borst GR, Belderbos JS, Boellaard R, Comans EF, De Jaeger K, Lammertsma AA, Lebesque JV.

Eur J Cancer. 2005 Jul;41(11):1533-41.

PMID:
15953716
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk